Ensign Peak Advisors Inc raised its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 160.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 105,490 shares of the company's stock after purchasing an additional 65,014 shares during the quarter. Ensign Peak Advisors Inc's holdings in Ryan Specialty were worth $6,768,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of RYAN. Barclays PLC raised its stake in shares of Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after purchasing an additional 17,267 shares during the period. Cooper Financial Group raised its stake in shares of Ryan Specialty by 9.9% in the 4th quarter. Cooper Financial Group now owns 3,808 shares of the company's stock valued at $244,000 after purchasing an additional 342 shares during the period. UMB Bank n.a. raised its stake in shares of Ryan Specialty by 5.7% in the 4th quarter. UMB Bank n.a. now owns 5,522 shares of the company's stock valued at $354,000 after purchasing an additional 298 shares during the period. SG Americas Securities LLC raised its stake in shares of Ryan Specialty by 94.2% in the 4th quarter. SG Americas Securities LLC now owns 3,253 shares of the company's stock valued at $209,000 after purchasing an additional 1,578 shares during the period. Finally, Janney Montgomery Scott LLC raised its stake in shares of Ryan Specialty by 4.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 17,825 shares of the company's stock valued at $1,144,000 after purchasing an additional 831 shares during the period. Institutional investors and hedge funds own 84.82% of the company's stock.
Insider Transactions at Ryan Specialty
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 11.10% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on RYAN. UBS Group lifted their target price on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Wells Fargo & Company lowered their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Barclays lowered their target price on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Keefe, Bruyette & Woods lowered their target price on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Finally, Royal Bank of Canada lowered their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $76.42.
Check Out Our Latest Research Report on Ryan Specialty
Ryan Specialty Stock Performance
Ryan Specialty stock traded up $0.80 during midday trading on Friday, reaching $70.67. 672,673 shares of the company's stock were exchanged, compared to its average volume of 979,617. Ryan Specialty Holdings, Inc. has a 52 week low of $52.34 and a 52 week high of $77.16. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a market cap of $18.55 billion, a price-to-earnings ratio of 102.42, a P/E/G ratio of 1.19 and a beta of 0.68. The stock's 50-day simple moving average is $70.16 and its 200 day simple moving average is $68.73.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting analysts' consensus estimates of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. During the same quarter last year, the company posted $0.35 earnings per share. Ryan Specialty's quarterly revenue was up 25.0% on a year-over-year basis. On average, analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, May 13th. Ryan Specialty's dividend payout ratio is presently 141.18%.
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.